Use of Cardiac Biomarkers for the Diagnosis of Myocardial Infarction and Heart Failure.

被引：0
|
作者：
Puelacher, C.
Hillinger, P.
Wagener, M.
Mueller, C. [1 ]
机构：
[1] Univ Spital Basel, Abt Kardiol, Petersgraben 4, CH-4031 Basel, Switzerland
来源：
JOURNAL FUR KARDIOLOGIE | 2015年 / 22卷 / 5-6期
关键词：
biomarkers; troponin; copeptin; AMI; BNP; adrenomedullin; heart failure; Gal-3;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Acute myocardial infarctions and heart failure compose the most common cardiac diseases and both present a diagnostic challenge. To aid clinicians in this task, an array of biomarkers, molecules representing different (patho-) physiologic mechanisms, have become available. This review aims to give an overview over this fast growing field, with an emphasis on the clinically most used (cardiac troponin and B-type natriuretic peptide), while also providing compact up-to-date information concerning new developments.
引用
收藏
页码：124 / 128
页数：5
相关论文
共 50 条
  • [41] A history of prior myocardial infarction was independently predictive of mortality but not of recurrent myocardial infarction or heart failure hospitalization in 5477 patients with acute myocardial infarction complicated by cardiac failure
    Willenheimer, R
    Gränsbo, K
    Snapinn, S
    Coats, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 153A - 153A
  • [42] Cardiac failure during myocardial infarction
    Saberin, A.
    Wagner, D. R.
    REVUE DE MEDECINE INTERNE, 2008, 29 : S3 - S5
  • [43] MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential
    Shah P.
    Bristow M.R.
    Port J.D.
    Current Heart Failure Reports, 2017, 14 (6) : 454 - 464
  • [44] Biomarkers of myocardial stress and fibrosis in determining clinical outcomes in patients with heart failure and previous myocardial infarction
    Shilyaeva, N.
    Medvedeva, E.
    Shpigel, A.
    Shchukin, Y.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 427 - 428
  • [45] Disruptions and detours in the myocardial matrix highway and heart failure.
    Deschamps A.M.
    Spinale F.G.
    Current Heart Failure Reports, 2005, 2 (1) : 10 - 17
  • [46] A strategy for the use of cardiac injury markers in the diagnosis of acute myocardial infarction
    Wilson, PR
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1998, 122 (11) : 949 - 949
  • [47] ICU Use and Quality of Care for Patients With Myocardial Infarction and Heart Failure
    Valley, Thomas S.
    Sjoding, Michael W.
    Goldberger, Zachary D.
    Cooke, Colin R.
    CHEST, 2016, 150 (03) : 524 - 532
  • [48] Proteomic biomarkers for diagnosis in acute myocardial infarction
    Park, Jong Pil
    Park, Moon Ki
    Yun, Jong Won
    BIOMARKERS, 2011, 16 (01) : 1 - 11
  • [49] Biomarkers in Acute Myocardial Infarction Diagnosis and Prognosis
    Martinez, Paula F.
    Oliveira-Junior, Silvio A.
    Polegato, Bertha F.
    Okoshi, Katashi
    Okoshi, Marina P.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2019, 113 (01) : 40 - 41
  • [50] Use of valsartan in post-myocardial infarction and heart failure patients
    Liu, Peter P.
    Maggioni, Aldo
    Velazquez, Eric J.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2006, 7 : S19 - S22
12345